Hopp til hovedinnhold
Addisons sykdom er en sjelden tilstand. Blant en million mennesker, regner man med at det vil være ca. fem nye tilfeller per år.
Addisons sykdom er en sjelden tilstand. Blant en million mennesker, regner man med at det vil være ca. fem nye tilfeller per år.

Addisons sykdom

Addisons sykdom skyldes binyrebarksvikt. Dette medfører at produksjonen av livsviktige hormoner reduseres. Symptomene kommer ofte gradvis, man føler seg svakere og mangler overskudd. Vekttap, magesmerter og diaré kan også forekomme.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hormoner-og-naring/binyresykdommer/addisons-sykdom/ 

Hva er Addisons sykdom?

Årsak

Diagnostikk

Behandling

Prognose

Oppfølging

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Binyrebarksvikt (Addisons sykdom). Referanselisten for dette dokumentet vises nedenfor.

  1. Charmandari E, Nicolaides NC,Chrousos GP. Adrenal insufficiency. Lancet. 2014 Jun 21;383(9935):2152-67. doi: 10.1016/S0140-6736(13)61684-0. DOI 
  2. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 364-89. pmid:26760044 PubMed 
  3. Husebye ES, Allolio B, Arlt W, et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-15. PMID: 24330030 PubMed 
  4. Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet 2021; 397: 613-629. pmid:33484633 PubMed 
  5. Bancos I, Hahner S, Tomlinson J, et al. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216-26. pmid:25098712 PubMed 
  6. Løvås K, Erichsen MM, Husebye ES, et al. Primær binyrebarksvikt - årsaker, diagnostikk og behandling. Tidsskr Nor Lægeforen 2005; 125: 155-8. PubMed 
  7. Tazmini K., Husebye ES., Løvås K. Binyrebarksvikt. Nasjonal veileder i endokrinologi. Norsk endokrinologisk forening. Sist oppdatert 31.03.2020. Siden lest 01.03.2021.
  8. Holmberg NH, Haagensen AL. Akutt binyrebarksvikt hos et barn. Kort kasuistikk. Tidsskr Nor Legeforen 2023. doi:10.4045/tidsskr.22.0354 DOI 
  9. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. Lancet 2001; 357: 425-31. PubMed 
  10. Labrie F, Luu-The V, Labrie C et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 2001; 22: 185-212. PubMed 
  11. Michels A, Michels N. Addison disease: early detection and treatment principles. Am Fam Physician. 2014 Apr 1;89(7):563-568. PubMed 
  12. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002; 23: 327-64. PubMed 
  13. Baker PR, Nanduri P, Gottlieb PA, et al. Predicting the onset of Addison's disease: ACTH, renin, cortisol, and 21-hydroxylase autoantibodies. Clin Endocrinol (Oxf). 2012;76(5):617–624.
  14. Kelestimur F. The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function. J Endocrinol Invest 2004; 27: 380-6. PubMed 
  15. Moser H, Dubey P, Fatemi A. Progress in X-linked adrenoleukodystrophy. Curr Opin Neurol 2004; 17: 263-9. PubMed 
  16. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 2003; 149: 79–90.
  17. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA 1999; 282: 671-6. Journal of the American Medical Association 
  18. Toogood AA. Endocrine consequences of brain irradiation. Growth Horm IGF Res 2004; 14(suppl A): S118-S124.
  19. Aimaretti G, Ambrosio MR, Di Somma C, et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf). 2004; 61: 320-6. PubMed 
  20. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) 1998; 49: 287-92. PubMed 
  21. Falorni A, Laureti S, Nikoshkov A, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison’s disease: Belgian diabetes registry. Clin Exp Immunol 1997; 107: 341-6 . PubMed 
  22. Eisenbarth GS and Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350: 2068-79. New England Journal of Medicine 
  23. Løvås K, Husebye ES. Kortisol i spytt ved sykdom i binyrene. Tidsskr Nor Lægeforen 2007; 127: 730-2. Tidsskrift for Den norske legeforening 
  24. Pfeifer M, Kanc K, Verhovec R, Koijianic A. Reproducibility of the ITT for assessment of GH and cortisol responses in normal and hypopituitaric adult men. Clin Endocrinol (Oxf) 2001; 54: 17-22. PubMed 
  25. Soule S, van Zyl Smit K, Parolis G, et al. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism. Clin Endocrinol (Oxf) 2000; 53: 221-7. PubMed 
  26. Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab. 2002; 87: 5470-5. PubMed 
  27. Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 2003; 88: 4193-8. PubMed 
  28. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361: 1881-93. PubMed 
  29. Løvas K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002; 56: 581-88. PubMed 
  30. Jeffcoate W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann Clin Biochem 1999; 36: 151-7. PubMed 
  31. Allolio B, Arlt W. DHEA treatment: myth or reality? Trends Endocrinol Metab 2002; 13: 288. PubMed 
  32. Grimley Evans J, Malouf R, Huppert FAH, Van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006221. Cochrane (DOI) 
  33. Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 2005; 90: 4394-8. PubMed 
  34. Salvatori R. Adrenal insufficiency. JAMA 2005; 294: 2481-8. PubMed